Literature DB >> 36047441

Paul Kleihues (1936-2022), neuropathology innovator and entrepreneur.

Adriano Aguzzi1, Andreas von Deimling2, Markus Glatzel3, David N Louis4, Otmar D Wiestler5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 36047441      PMCID： PMC9048510          DOI： 10.1111/bpa.13073

Source DB:  PubMed          Journal:  Brain Pathol        ISSN： 1015-6305            Impact factor:   7.611


× No keyword cloud information.
  5 in total

1.  Brain Pathology moves to open access.

Authors:  Markus Glatzel; Seth Love
Journal:  Brain Pathol       Date:  2020-12-10       Impact factor: 6.508

2.  Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain deoxyribonucleic acid during repetitive administration of N-methyl-N-nitrosourea.

Authors:  G P Margison; P Kleihues
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

3.  Genetic pathways to glioblastoma: a population-based study.

Authors:  Hiroko Ohgaki; Pierre Dessen; Benjamin Jourde; Sonja Horstmann; Tomofumi Nishikawa; Pier-Luigi Di Patre; Christoph Burkhard; Danielle Schüler; Nicole M Probst-Hensch; Paulo César Maiorka; Nathalie Baeza; Paola Pisani; Yasuhiro Yonekawa; M Gazi Yasargil; Urs M Lütolf; Paul Kleihues
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

Review 4.  The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.

Authors:  Tejus A Bale; Marc K Rosenblum
Journal:  Brain Pathol       Date:  2022-02-25       Impact factor: 7.611

Review 5.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.